Multi-analyte screening panels are redefining toxicology drug screening, enabling labs to detect dozens of substances—including drugs, environmental toxins, and even biomarkers of organ damage—in a single test. These panels are replacing traditional single-target tests, offering efficiency, cost savings, and deeper insights into patient or sample profiles. For pharmaceutical firms,...
North America holds a major share of the drug abuse testing market due to established testing regulations, high demand for workplace safety programs, and advanced healthcare infrastructure. The region continues to witness increased adoption of point-of-care testing solutions and innovative screening technologies as organizations focus on substance abuse prevention, regulatory compliance, and...